CH633188A5 - Medicament contre des maladies infectieuses des voies respiratoires. - Google Patents

Medicament contre des maladies infectieuses des voies respiratoires. Download PDF

Info

Publication number
CH633188A5
CH633188A5 CH580578A CH580578A CH633188A5 CH 633188 A5 CH633188 A5 CH 633188A5 CH 580578 A CH580578 A CH 580578A CH 580578 A CH580578 A CH 580578A CH 633188 A5 CH633188 A5 CH 633188A5
Authority
CH
Switzerland
Prior art keywords
nctc
lysate
respiratory tract
bacterial
infectious diseases
Prior art date
Application number
CH580578A
Other languages
English (en)
French (fr)
Inventor
Jean-Claude Farine
Anne Rivkine
Isidro Bulto
Original Assignee
Om Laboratoires Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4299594&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CH633188(A5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Om Laboratoires Sa filed Critical Om Laboratoires Sa
Priority to CH580578A priority Critical patent/CH633188A5/fr
Priority to DE2917730A priority patent/DE2917730C2/de
Priority to BE0/195087A priority patent/BE876164A/xx
Priority to ES480448A priority patent/ES480448A1/es
Priority to CS793429A priority patent/CS222673B2/cs
Priority to RO7997611A priority patent/RO78451A/ro
Priority to FR7913157A priority patent/FR2426470A1/fr
Priority to DD79213101A priority patent/DD143729A5/de
Priority to IT49157/79A priority patent/IT1116213B/it
Priority to PL1979215824A priority patent/PL126416B1/pl
Priority to YU1236/79A priority patent/YU41864B/xx
Priority to HU79LA957A priority patent/HU180005B/hu
Priority to PT69674A priority patent/PT69674A/pt
Priority to GB7918310A priority patent/GB2021415B/en
Priority to JP6411579A priority patent/JPS54154509A/ja
Publication of CH633188A5 publication Critical patent/CH633188A5/fr
Priority to HRP-1236/79A priority patent/HRP921281B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CH580578A 1978-05-26 1978-05-26 Medicament contre des maladies infectieuses des voies respiratoires. CH633188A5 (fr)

Priority Applications (16)

Application Number Priority Date Filing Date Title
CH580578A CH633188A5 (fr) 1978-05-26 1978-05-26 Medicament contre des maladies infectieuses des voies respiratoires.
DE2917730A DE2917730C2 (de) 1978-05-26 1979-05-02 Immunobiotherapeutisches Arzneipräparat gegen Infektionen der Atemwege und Verfahren zu seiner Herstellung
BE0/195087A BE876164A (fr) 1978-05-26 1979-05-10 Medicament contre des maladies infectieuses des voies respiratoires
ES480448A ES480448A1 (es) 1978-05-26 1979-05-10 Procedimiento de fabricacion de medicamentos inmunobioterapicos.
CS793429A CS222673B2 (en) 1978-05-26 1979-05-17 Method of making the immunobiotherapeutic means against infection disease of the breathing ways
RO7997611A RO78451A (ro) 1978-05-26 1979-05-22 Procedeu de obtinere a unui medicament imunobioterapeutic impotriva maladiilor infectioase ale cailor respiratorii
DD79213101A DD143729A5 (de) 1978-05-26 1979-05-23 Verfahren zur herstellung eines immunbiotherapeutischen arzneimittels gegen infektionen der atemwege
FR7913157A FR2426470A1 (fr) 1978-05-26 1979-05-23 Medicament immunobiotherapique contre des maladies infectieuses des voies respiratoires
IT49157/79A IT1116213B (it) 1978-05-26 1979-05-24 Medicamento immunobioterapico a base di lisato batterico e relativo terreno di coltura
PL1979215824A PL126416B1 (en) 1978-05-26 1979-05-24 Method of obtaining immunobiotherapeutic preparation counteractive against respiratory system diseases
YU1236/79A YU41864B (en) 1978-05-26 1979-05-25 Process for obtainin a bacterial lysate
HU79LA957A HU180005B (en) 1978-05-26 1979-05-25 Process for producing pharmaceutical composition utilizable for treating illnesses of respiratory organs
PT69674A PT69674A (pt) 1978-05-26 1979-05-25 Procede de preparation d'un medicament contre les maladiesinfectieuses des voies respiratoires
GB7918310A GB2021415B (en) 1978-05-26 1979-05-25 Bacterial lysates for treating infections of the respiratory passages
JP6411579A JPS54154509A (en) 1978-05-26 1979-05-25 Immunological organism treating agent for treating infectious disease airr passage
HRP-1236/79A HRP921281B1 (en) 1978-05-26 1992-11-16 Process for the preparation of bacterium lisate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH580578A CH633188A5 (fr) 1978-05-26 1978-05-26 Medicament contre des maladies infectieuses des voies respiratoires.

Publications (1)

Publication Number Publication Date
CH633188A5 true CH633188A5 (fr) 1982-11-30

Family

ID=4299594

Family Applications (1)

Application Number Title Priority Date Filing Date
CH580578A CH633188A5 (fr) 1978-05-26 1978-05-26 Medicament contre des maladies infectieuses des voies respiratoires.

Country Status (15)

Country Link
JP (1) JPS54154509A (xx)
BE (1) BE876164A (xx)
CH (1) CH633188A5 (xx)
CS (1) CS222673B2 (xx)
DD (1) DD143729A5 (xx)
DE (1) DE2917730C2 (xx)
ES (1) ES480448A1 (xx)
FR (1) FR2426470A1 (xx)
GB (1) GB2021415B (xx)
HU (1) HU180005B (xx)
IT (1) IT1116213B (xx)
PL (1) PL126416B1 (xx)
PT (1) PT69674A (xx)
RO (1) RO78451A (xx)
YU (1) YU41864B (xx)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4104728A1 (de) * 1990-02-16 1991-08-22 Om Lab Sa Medikament zur behandlung der dermatitis
US5424287A (en) * 1992-02-14 1995-06-13 Laboratoires Om Sa Extract of bacterial macromolecules, a process for its preparation and a pharmaceutical composition containing the same

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2550707B1 (fr) * 1983-08-17 1986-02-28 Lipha Medicament immunomodulateur d'origine biologique et son procede de preparation
WO1997045530A1 (fr) * 1996-05-27 1997-12-04 UZILOVA, Irina Semenovna, Heiress of UZILOV Utilisation de souches de streptococcus faecium et composition a base de ces souches
SE511648C2 (sv) * 1998-04-17 1999-11-01 Bacterum Ab Streptokockpreparat för behandling av öroninflammation
PL2114421T3 (pl) * 2007-03-05 2018-07-31 Om Pharma Ekstrakt bakteryjny do stosowania względem zaburzeń oddechowych i sposób jego wytwarzania
CN104922330A (zh) * 2015-07-15 2015-09-23 龚灿锋 一种治疗扁桃体炎的中药

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE543985A (xx) *
FR2892M (fr) * 1963-07-25 1964-11-02 Inst Rech Scient Substances a action immunisante et désensibilisante.
FR6513M (xx) * 1967-07-12 1968-12-02
FR7010M (xx) * 1967-11-10 1969-06-02
FR7461M (xx) * 1968-06-19 1970-01-05
US3929994A (en) * 1969-05-20 1975-12-30 Roussel Uclaf Anti-inflammatory glycoprotein compositions and method of use
NL174267B (nl) * 1969-05-20 Roussel Uclaf Verbetering van de werkwijze voor de bereiding van een somatisch antigeen volgens het nederlandse octrooischrift 169754 en werkwijze ter bereiding van een farmaceutisch preparaat.
BE795417A (fr) * 1972-02-15 1973-08-14 Roussel Uclaf Nouveaux composes d'origine-bacterienne et procede d'obtention
FR2253499B1 (xx) * 1973-12-10 1977-11-04 Fabre Sa Pierre
GB1518277A (en) * 1974-09-06 1978-07-19 Inst Rech Chem Et Biolog Appli Antigenic composition
FR2307542A1 (fr) * 1975-04-14 1976-11-12 Synthelabo Nouvelle preparation immunostimulante
FR2315944A1 (fr) * 1975-07-04 1977-01-28 Tournade Francois Preparation pharmaceutique presentant une action de stimulation immunitaire non specifique de l'organisme

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4104728A1 (de) * 1990-02-16 1991-08-22 Om Lab Sa Medikament zur behandlung der dermatitis
AT402152B (de) * 1990-02-16 1997-02-25 Om Lab Sa Verwendung eines bakterien-lysats zur herstellung eines medikaments zur behandlung der atopischen dermatitis
DE4104728C2 (de) * 1990-02-16 1999-01-14 Om Lab Sa Verwendung eines Bakterien-Lysats zur Behandlung der atopischen Dermatitis
US5424287A (en) * 1992-02-14 1995-06-13 Laboratoires Om Sa Extract of bacterial macromolecules, a process for its preparation and a pharmaceutical composition containing the same

Also Published As

Publication number Publication date
FR2426470A1 (fr) 1979-12-21
DE2917730C2 (de) 1986-04-03
CS222673B2 (en) 1983-07-29
JPS6337770B2 (xx) 1988-07-27
DD143729A5 (de) 1980-09-10
IT1116213B (it) 1986-02-10
FR2426470B1 (xx) 1983-08-05
PL215824A1 (xx) 1980-02-11
YU123679A (en) 1983-04-30
DE2917730A1 (de) 1979-11-29
GB2021415A (en) 1979-12-05
PT69674A (pt) 1979-06-01
BE876164A (fr) 1979-09-03
IT7949157A0 (it) 1979-05-24
ES480448A1 (es) 1979-12-16
PL126416B1 (en) 1983-08-31
HU180005B (en) 1983-01-28
GB2021415B (en) 1983-03-30
YU41864B (en) 1988-02-29
RO78451A (ro) 1982-02-26
JPS54154509A (en) 1979-12-05

Similar Documents

Publication Publication Date Title
Ooshima et al. Caries inhibitory activity of cacao bean husk extract in in-vitro and animal experiments
Bryan et al. Problems in salmonellosis: rationale for clinical trials with newer β-lactam agents and quinolones
US6017528A (en) Therapeutic treatment of group A streptococcal infections
Davies et al. Serum and sputum concentrations of enoxacin after single oral dosing in a clinical and bacteriological study
Nilsen et al. A double blind study of single dose azithromycin and doxycycline in the treatment of chlamydial urethritis in males.
CH633188A5 (fr) Medicament contre des maladies infectieuses des voies respiratoires.
Kamme et al. Evaluation of spiramycin as a therapeutic agent for elimination of nasopharyngeal pathogens: possible use of spiramycin for middle ear infections and for gonococcal and meningococcal nasopharyngeal carriage
BE1005589A3 (fr) Medicament pour le traitement de la dermatite.
Fitzgerald et al. Inhibition of oral spirochetes by antibiotic agents in vitro
US4223040A (en) Lauric acid for the prevention and treatment of mycobacterial diseases
JPH0255407B2 (xx)
JP3665850B2 (ja) 免疫賦活剤
Jamieson et al. Bacillary Dysentery in Dundee: A Comparative Study of Treatments
Dixon et al. Enhancement of ethanol toxicity by ethacrynic acid
Puhakka et al. Cefadroxil in the treatment of susceptible infections in infants and children
RU2239451C2 (ru) Способ терапевтического или профилактического лечения стрептококковых инфекций (варианты) и композиция, предназначенная для использования в нем (варианты), лизиновый фермент, ассоциированный с фагом стрептококков группы с,- активный агент фармацевтической композиции
Yu et al. On the mechanism of action of griseofulvin in dermatophytosis
Shaw Ineffectiveness of low molecular weight dextrans in the prevention of experimental dental caries in mutant albino rats
FR2536281A1 (fr) Compositions pharmaceutiques permettant de reguler les fonctions phagocytaires
RU2101020C1 (ru) Препарат, обладающий иммуностимулирующим действием
JPS6084302A (ja) アラビノガラクタンおよびその製法
Gillespie Experiments on the antibacterial properties of pyridium and serenium
RU2245156C1 (ru) Способ профилактики хламидийного гастроэнтерита телят
Takahashi et al. Biological properties of macarbomycin, an antibiotic containing phosphorus
GANNON Physiological growth studies of Entamoeba gingivalis

Legal Events

Date Code Title Description
PL Patent ceased